ArticleBlood advances2018

Transient loss of detectable HIV-1 RNA following brentuximab vedotin anti-CD30 therapy for Hodgkin lymphoma.

Chia-Ching Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.